Home › Funds › Defilade Capital Management, L.P. › LRMR
Defilade Capital Management, L.P. position in LRMR
LARIMAR THERAPEUTICS INC · Health Care
Defilade Capital Management, L.P. reported holding 4,934,439 shares of LRMR (LARIMAR THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$15.8M, representing 2.63% of its reported portfolio and ranking #18 among its reported holdings. Defilade Capital Management, L.P. has disclosed LRMR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Defilade Capital Management, L.P.'s LRMR position evolved
Defilade Capital Management, L.P. first disclosed a stake in LRMR in Q2 2026 at 3,670,135 shares (US$11.2M). The position peaked in Q3 2026 at 4,934,439 shares, worth US$15.8M. Across 2 filings, Defilade Capital Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,934,439 shares valued at US$15.8M — an increase of 1,264,304 shares quarter over quarter.. Notable position changes include a 34% increase in Q3 2026 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 3.67M | $11.19M | New |
| Q3 2026 | 4.93M | $15.77M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LRMR and 13F data
LRMR (LARIMAR THERAPEUTICS INC) is a Health Care company. 30 other funds we track also report a position in LRMR — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$113.8M), Blue Owl Capital Holdings LP (US$31.7M), DAFNA Capital Management LLC (US$6.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LRMR
- DEERFIELD MANAGEMENT COMPANY, L.P. 35.61M sh · $113.76M · Q3 2026
- Blue Owl Capital Holdings LP 9.92M sh · $31.71M · Q3 2026
- DAFNA Capital Management LLC 1.89M sh · $6.03M · Q3 2026
- AIGH Capital Management LLC 1.85M sh · $5.91M · Q3 2026
More on Defilade Capital Management, L.P.
FAQ
How long has Defilade Capital Management, L.P. held LRMR?
Defilade Capital Management, L.P. has disclosed LRMR holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Defilade Capital Management, L.P.'s current position in LRMR?
As of Q3 2026, Defilade Capital Management, L.P. holds 4.93M shares of LRMR (LARIMAR THERAPEUTICS INC), valued at $15.77M, representing 2.63% of its reported portfolio and ranking #18.
Has Defilade Capital Management, L.P. been buying or selling LRMR?
In the latest 13F filing (Q3 2026), Defilade Capital Management, L.P. increased its position in LRMR. The position peaked in Q3 2026 at 4.93M shares.
Which other funds hold LRMR?
Other major institutional holders of LRMR include DEERFIELD MANAGEMENT COMPANY, L.P., Blue Owl Capital Holdings LP, DAFNA Capital Management LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.